1-5 of 5 results for subject:Celltech
Librarians' tools
- Search time
- 0.225 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Celltech
- We searched for
- subject_t:Celltech OR subject_t:"Celltech Biologics" OR subject_t:"Celltech Therapeutics" OR subject_ses:19278
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health, when the tuberculosis vaccine will be available in the South West. - (Holding answer 8 January 2001).
To ask the Secretary of State for Health, when the tuberculosis vaccine will be available in the South West. - (Holding answer 8 January 2001).
Asked by
Lord Burnett
(Liberal Democrat)
Answered by
Yvette Cooper
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
21 December 2000
For answer on
9 January 2001
Answered on
9 January 2001
Mr. Burnett: To ask the Secretary of State for Health when the tuberculosis vaccine will be available in the south-west. [144433]
Yvette Cooper: [holding answer 8 January 2001]:
BCG vaccine against tuberculosis is currently available in the south-west for those individuals at higher risk of TB. Routine
immunisation of all school children at age 10-14 was suspended in September 1999 due to severe manufacturing problems encountered by
the sole United Kingdom licensed source, Celltech Medeva.
The Department is doing all it can to secure a robust supply of UK licensed and batch released BCG vaccine, and will announce as
soon as possible when the routine schools programme can resume. All those who missed their BCG vaccination due to the suspension of
the programme will be recalled as part of a catch up programme.
Subjects
Children; Disease control; Schools; Vaccination; Tuberculosis; Celltech
Date
9 January 2001
Reference
360 c539W; 144433
House
House of Commons
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Notes
Received 27.01.94
Subjects
British Telecom; British Gas; Policy; Ministry of Defence; United Kingdom Atomic Energy Authority; Technology; Research; Science; Scottish Office; British Aerospace; Department of the Environment; Advisory Board for the Research Councils; Glaxo; Association of Medical Research Charities; Association of Innnovation Research and Technology Organisations; Association of Researchers in Medicine and Science; Celltech; Institute of Biology; Ministry of Agriculture, Fisheries and Food; Association for the Study of Animal Behaviour; Edinburgh Centre for Rural Research; Institute of Ecology and Resource Management; Jeffreys, Alec; Searle, JB; Houslay, Miles; Dunnill, Peter; Matthews, JBL
Commons Library location
Research Sc 351.855,P
Date
15 December 1993
Reference
HL 12 1993/94
House
House of Lords
Type
House of Lords papers; Select Committee written evidence;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Subjects
Biotechnology; Genetic engineering; Genetically modified organisms; Regulation; Agricultural and Food Research Council; Trade competitiveness; Confederation of British Industry; Chemical Industries Association; Bayer; British Society of Plant Breeders; British Sugar Beet Seed Producers Association; Bioindustry Association; Brewers Society; Celltech; Ciba-Geigy Chemicals; Agricultural Genetics; Biocatalysts; British Biotechnology; Cantab Pharmaceuticals; Weatherall, David; Kindersley, Julian; Cripps, Yvonne; Brenner, Sidney; Durant, John; Slabas, AR; Lilly, MD; Parsons, JW; Harris, John B; Onions, David; Grierson, Don; Goldspink, Geoffrey; Macdonald, Jose; Dale, JE; Berry, DR; Burke, Derek C; Bryce, CFA; Boulter, D; Marino, Gennaro; Peters, Keith; Williamson, Mark; Wright, M; Orskov, ER; Fairtlough, Gerard
Date
10 June 1993
Reference
HL 80-I 1992/93
House
House of Lords
Type
Select Committee reports; House of Lords papers;
Parliamentary committees
Committee
Science and Technology Committee (HL)
Notes
Received 24.05.93
Subjects
Biotechnology; Genetic engineering; Genetically modified organisms; Regulation; Trade competitiveness; Celltech; Agricultural Genetics; Animal Biotechnology; British Biotechnology
Date
15 April 1993
Reference
HL 80-iv 1992/93
House
House of Lords
What arrangement exist between MRC & Celltech on the exploitation of research results
What arrangement exist between MRC & Celltech on the exploitation of research results
Asked by
Lord Watson of Invergowrie
(Labour)
Answered by
Robert Jackson
(Conservative)
Answering body
Department of Education and Science
Type
Written questions
Status
Answered
For answer on
14 December 1989
Answered on
14 December 1989
Subjects
Innovation; Medicine; Research; Medical Research Council; Celltech
Date
14 December 1989
Reference
163 c739W
House
House of Commons